share_log

博腾股份(300363.SZ):第三季度净亏损3639.32万元

Porton Pharma Solutions (300363.SZ): The net loss in the third quarter was 36.3932 million yuan.

Gelonghui Finance ·  Oct 24 16:47

Porton Pharma Solutions (300363.SZ) released its third-quarter report on October 24th. In the third quarter of 2024, the company achieved revenue of 0.773 billion yuan, a year-on-year increase of 10.73%; net income attributable to shareholders of the listed company was a loss of 36.3932 million yuan, a year-on-year decrease of 187.72%; net income loss after deducting non-recurring gains and losses was 39.393 million yuan, a year-on-year decrease of 211.61%; basic earnings per share were a loss of 0.07 yuan/share.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment